Literature DB >> 26339182

Erratum: A Phase 2 Multi-center, Open-label, Switch-over Trial to Evaluate the Safety and Efficacy of Abcertin® in Patients with Type 1 Gaucher Disease.

Jin-Ho Choi, Beom Hee Lee, Jung Min Ko, Young Bae Sohn, Jin-Sung Lee, Gu-Hwan Kim, Sun Hee Heo, June-Young Park, Yoo-Mi Kim, Ja-Hye Kim, Han-Wook Yoo.   

Abstract

Entities:  

Year:  2015        PMID： 26339182      PMCID： PMC4553689          DOI： 10.3346/jkms.2015.30.9.1373

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN： 1011-8934            Impact factor:   2.153


× No keyword cloud information.
  1 in total

1.  The road to biosimilars in rare diseases - ongoing lessons from Gaucher disease.

Authors:  Guillermo Drelichman; Gilberto Castañeda-Hernández; Muhlis Cem Ar; Marta Dragosky; Ricardo Garcia; Howard Lee; Sergey Moiseev; Majid Naderi; Hanna Rosenbaum; Irena Žnidar; Andrés Felipe Zuluaga; Selena Freisens; Pramod K Mistry
Journal:  Am J Hematol       Date:  2019-12-23       Impact factor: 10.047
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.